Table 3. BALB/c mice injected with iSPZ-loaded hepatocytes are protected against SPZ challenge.
2 weeks after challenge | ||||
Mouse group (n of SPZ for challenge) | Treatment | Mice protected/total challenged | % of protection | p-value: IS versus naive |
A (2000) | IS | 5/5 | 100 | 0.167 |
Naive | 2/5 | 40 | ||
B (5000) | IS | 2/6 | 33 | 0.125 |
Naive | 0/10 | 0 | ||
Total | IS | 7/11 | 64 | 0.014 |
Naive | 2/15 | 13 |
BALB/c mice were injected (IS transfer) with 7×105 PbiSPZ-infected or naïve BALB/c hepatocytes. Infected hepatocytes were obtained from BALB/c mice immunized with 106 ANKA wt iSPZ 2 h earlier. Recipient mice were then challenged with two different doses (2×103 and 5×103, respectively, A and B) of live PbSPZ one week later. Mice were considered protected if they remained parasite negative 2 weeks after challenge.